Discover Opportunities. Start Here
OpenAI has announced the postponement of its highly anticipated GPT-6.1 Astra system, originally slated for release next month, due to significant safety concerns. The decision comes after internal assessments revealed…
The publishing industry, a bastion of human creativity and narrative, is grappling with an unprecedented challenge: the pervasive and often clandestine use of artificial intelligence by authors. As scandals mount,…
As the geopolitical landscape of artificial intelligence intensifies, with nations and corporations fiercely debating access to cutting-edge AI capabilities, French AI powerhouse Mistral has launched a significant new open-weight model.…
The intersection of escalating geopolitical tensions and remarkably resilient consumer demand for travel is creating an unprecedented environment for the global aviation industry, threatening to sustain elevated airfares throughout the…
In a development that has sent ripples of both awe and apprehension through the global mathematical community, OpenAI convened a gathering of approximately 40 leading mathematicians in August to confront…
David Ellison, CEO of Skydance, and Ynon Kreiz, the incoming co-CEO, on Monday unveiled the comprehensive executive leadership team poised to steer the newly formed media and entertainment behemoth, Skydance,…
British Airways is embarking on an ambitious transformation of its Airbus A380 fleet, introducing what it touts as the "world’s largest" business-class cabin while simultaneously reducing dozens of economy-class seats.…
The AI Era, for many, ignited in late 2022 with the public debut of OpenAI’s ChatGPT, a generative AI model that rapidly captured the world’s imagination and surpassed 100 million…
Los Angeles, California – A monumental shift in the global entertainment industry has culminated today as Skydance, the David Ellison-led media company, officially closed its acquisition of Warner Bros. Discovery…
Pascal Soriot, Chief Executive Officer of global pharmaceutical giant AstraZeneca, articulated a compelling vision for the future of cancer care on Monday, emphasizing that a lead drug from biotech firm…
